Marc J. M. Bonten
Utrecht University
664 Papers
2.8K Citations
Marc J. M. Bonten is an academic researcher from Utrecht University. The author has contributed to research in topics: Medicine & Intensive care. The author has an hindex of 88, co-authored 600 publications. Previous affiliations of Marc J. M. Bonten include University Medical Center Utrecht & Oklahoma State University Center for Health Sciences.
Chat about Author
Papers
Transmissibility of Livestock-associated Methicillin-Resistant Staphylococcus aureus
TL;DR: A 6-month nationwide study to quantify the single-admission reproduction number, RA, for LA-MRSA in 62 hospitals in the Netherlands and to compare this transmission capacity to previous estimates found it to be 4.4 times lower than that of other MRSA (not associated with livestock).
Bacteremic Complications of Intravascular Catheters Colonized with Staphylococcus aureus
Miquel B. Ekkelenkamp,Tjomme van der Bruggen,David A. M. C. van de Vijver,Tom F.W. Wolfs,Marc J. M. Bonten +4 more
TL;DR: Treated patients with Staphylococcus aureus colonization of an intravascular catheter but without demonstrated bacteremia within 24 h after intrav vascular catheter removal led to an 83% reduction in the incidence of subsequent bacterenmia.
Efficacy of BCG Vaccination Against Respiratory Tract Infections in Older Adults During the Coronavirus Disease 2019 Pandemic
Simone J.C.F.M. Moorlag,Esther Taks,Thijs ten Doesschate,Thomas W. van der Vaart,Axel B. Janssen,Lisa Müller,Philipp Niklas Ostermann,Helga Dijkstra,Heidi Lemmers,Elles Simonetti,Mark H. Mazur,Heiner Schaal,Rob ter Heine,Frank L. van de Veerdonk,Chantal P. Bleeker-Rovers,Reinout van Crevel,Jaap ten Oever,Marien I. de Jonge,Marc J. M. Bonten,Cornelis H. van Werkhoven,Mihai G. Netea +20 more
TL;DR: BCG vaccination had no effect on the incidence of RTIs, including SARS-CoV-2 infection, in older adult volunteers, however, it improved cytokine responses stimulated by influenza and SARS, and induced stronger antibody titers after COVID-19 infection.
Optimizing design of research to evaluate antibiotic stewardship interventions: consensus recommendations of a multinational working group
Valentijn A. Schweitzer,C.H. van Werkhoven,J Rodríguez Baño,Julia Bielicki,Stéphan Juergen Harbarth,Marlies E J L Hulscher,Benedikt Huttner,J. Islam,Paul Little,Céline Pulcini,Alessia Savoldi,Evelina Tacconelli,J. F. Timsit,M. van Smeden,Martin Wolkewitz,Marc J. M. Bonten,Anne-Sophie Walker,Anne-Sophie Walker,M J Llewelyn +18 more
TL;DR: A theoretical framework in which consideration of the intervention rationale the intervention setting, intervention features and the intervention aims inform selection and prioritization of outcome measures is proposed, which will help researchers, funders and practitioners to most efficiently evaluate antimicrobial stewardship interventions.
63
Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial.
Bruno François,Hasan S Jafri,Jean Chastre,Miguel Sánchez-García,Philippe Eggimann,Pierre-François Dequin,Vincent Huberlant,Lucia Viña Soria,Thierry Boulain,Cédric Bretonnière,Jérôme Pugin,Josep Trenado,Ana Catalina Hernandez Padilla,Omar Ali,Kathryn Shoemaker,Pin Ren,Frank E. J. Coenjaerts,Alexey Ruzin,Olivier Barraud,Leen Timbermont,Christine Lammens,Vadryn Pierre,Yuling Wu,Julie Vignaud,Susan Colbert,Terramika Bellamy,Mark T. Esser,Filip Dubovsky,Marc J. M. Bonten,Herman Goossens,Pierre-François Laterre,Didier Chochrad,Alain Dive,Frédéric Foret,Marc Simon,Herbert Spapen,Jacques Creteur,Yves Bouckaert,Patrick Biston,Marc Bourgeois,Martin Nováček,Tomas Vymazal,Petr Svoboda,Jan Pachl,Vladimir Sramek,Michal Hanauer,Tomas Hruby,Martin Balik,Tomas Suchy,Alain Lepape,Laurent Argaud,Frédéric Dailler,Arnaud Desachy,Christophe Guitton,Alain Mercat,Ferhat Meziani,Jean-Christophe Navellou,René Robert,Bertrand Souweine,Jean-Marc Tadie,Adel Maamar,Djillali Annane,Fabienne Tamion,Antoine Gros,Saad Nseir,Carole Schwebel,Gilles Francony,Jean-Yves Lefrant,Francis Schneider,Matthias Gründling,Johann Motsch,Lorenz Reill,Caroline Rolfes,Tobias Welte,Oliver A. Cornely,Frank Bloos,Maria Deja,Katrin Schmidt,Frank Wappler,Andreas Meier-Hellmann,Apostolos Komnos,Vasileios Bekos,Vasilios Koulouras,Ioanna Soultati,Georgios Baltopoulos,Georgios Filntisis,Epaminondas Zakynthinos,Spyros Zakynthinos,Ioannis Pnevmatikos,Ildikó Krémer,Zoltán Szentkereszty,Agnes Sarkany,Zsuzsa Marjanek,Pedro Moura,Maria Consuelo Pintado Delgado,Juan Carlos Montejo González,Paula Ramirez,Antonio Torres Marti,Juan Carlos Valia,Jose Lorente,Ana Loza Vazquez,Raúl De Pablo Sanchez,Dolores Escudero,Ricard Ferrer Roca,Jean-Luc Pagani,Marco Maggiorini +105 more
TL;DR: In this article, the authors evaluated the efficacy of suvratoxumab, a monoclonal antibody targeting the α toxin, in reducing the incidence of S aureus pneumonia in patients in the intensive care unit (ICU) who are on mechanical ventilation.